Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation
Open Access
- 1 December 2014
- journal article
- review article
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 23 (134) , 488-497
Abstract
Pulmonary arterial hypertension (PAH) is a rare disease leading to right heart failure and death. Prognosis remains poor, particularly for patients with severe disease,i.e.World Health Organization functional class IV. There have been significant improvements in treatment options. Several agents are available that target the three main established PAH disease pathways, and can be combined sequentially or upfront. Strong scientific evidence supports the use of intravenous epoprostenol in severe PAH; however, despite recommendations, many patients do not receive parenteral prostanoids and there is a lack of evidence from randomised clinical trials supporting the value of other PAH medications alone in severe PAH.Lung transplantation is an important option in patients with severe PAH who have not responded sufficiently to therapy, or who have worsened despite maximal treatment. Bridging techniques are available for patients who worsen while awaiting transplantation. The type of bridging technique used depends on various factors including patient illness severity, physician experience and the anticipated waiting time for transplantation. With the aim to facilitate the treatment decision-making process, herein we review the medical treatment options available for patients with severe PAH, and the bridging techniques that may be used to sustain patients awaiting transplantation.Keywords
This publication has 83 references indexed in Scilit:
- Recipient risk factors and lung transplant outcomesCurrent Opinion in Organ Transplantation, 2013
- Management of Severe Pulmonary Arterial HypertensionSeminars in Respiratory and Critical Care Medicine, 2013
- Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow?European Respiratory Review, 2013
- Macitentan and Morbidity and Mortality in Pulmonary Arterial HypertensionNew England Journal of Medicine, 2013
- Treadmill testing improves survival prediction models in pulmonary arterial hypertensionAmerican Heart Journal, 2011
- How to ReconditionEx VivoInitially Rejected Donor Lungs for Clinical Transplantation: Clinical Experience from Lund University HospitalJournal of Transplantation, 2011
- Lung Transplantation for Pulmonary HypertensionPulmonary Circulation, 2011
- Impact of the Lung Allocation Score on Lung Transplantation for Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLungThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2004